A Hidden Tradeoff in Trump’s MFN Drug Deals

U.S. government can take share of Canadian drug sales under pricing deals, documents suggest

Canada one of eight countries targeted in agreements struck with Pfizer and Eli Lilly

A hidden tradeoff in Trump’s MFN drug deals

The government has announced pricing agreements with 26 pharma companies. But the deals could stymie other plans to lower the country’s drug spend.

Secret Trump Drug Deals Reveal Perks For Big Pharma, Uncertainty For Patients | The Ashland Chronicle-Oregon

AstraZeneca CEO Pascal Soriot (left) shakes hands with U.S. President Donald Trump in the Oval Office of the White House as Health and Human Services Secretary Robert F. Kennedy Jr. stands by on October 10, 2025 in Washington, DC. (Photo by Andrew Harnik/Getty Images) Secret Trump Drug Deals Reveal Perks for Big Pharma, Uncertainty for Patients “The Trump team appears to be doing more to protect pharma profits than patients’ pocketbooks,” said …